Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 2876-2883, August 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, A. W.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, A. W.
Right arrow Articles by Conney, A. H.

Mutagenicity of the Dihydrodiols and Bay-Region Diol-Epoxides of Benzo(c)phenanthrene in Bacterial and Mammalian Cells

Alexander W. Wood1, Richard L. Chang, Wayne Levin, Dene E. Ryan, Paul E. Thomas, Martine Croisy-Delcey, Yitzhak Ittah, Haruhiko Yagi, Donald M. Jerina and Allan H. Conney

Department of Biochemistry and Drug Metabolism, Hoffmann-La Roche Inc., Nutley, New Jersey 07110 [A. W. W., R. L. C., W. L., D. E. R., P. E. T., A. H. C.], and Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, NIH, Bethesda, Maryland 20205 [M. C-D., Y. I., H. Y., D. M. J.]

The mutagenic activity of benzo(c)phenanthrene and some of its known and potential metabolites was evaluated in bacterial and mammalian cells either in the presence or absence of a metabolic activation system. trans-3,4-Dihydroxy-3,4-dihydrobenzo(c)phenanthrene [benzo(c)phenanthrene 3,4-dihydrodiol] was metabolized by a cytochrome P-450-dependent monooxygenase system to products which were severalfold more mutagenic to strains TA98 and TA100 of Salmonella typhimurium than were the metabolic products formed from benzo(c)phenanthrene or its 1,2- or 5,6-dihydrodiols. When the double bond in the 1,2-position of benzo(c)phenanthrene 3,4-dihydrodiol was replaced by a single bond, the resulting tetrahydrodiol could not be metabolically activated, suggesting that one or both diastereomeric bay-region diol-epoxides was the bioactivated metabolite of the 3,4-dihydrodiol of benzo(c)phenanthrene. Both of these bay-region diol-epoxide diastereomers were highly mutagenic in bacterial and mammalian cells and were very poor substrates for epoxide hydrolase. (±)-3{alpha},4ß-Dihydroxy-1ß,2ß-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene (diol-epoxide 1), in which the epoxide oxygen and the benzylic hydroxyl group are cis, induced histidine prototrophy in strains TA98 and TA100 of S. typhimurium at a mutation rate of 1000 and 2700 revertants/nmol, respectively. A 1 µM concentration of this diol-epoxide killed one-half of the treated Chinese hamster V79 cells and induced mutations in the surviving cells at a rate of 100 8-azaguanine-resistant cells/105 surviving cells. (±)-3{alpha},4ß-Dihydroxy-1{alpha},2{alpha}-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene (diol-epoxide 2), in which the epoxide oxygen and the benzylic hydroxyl group are trans, had from 80 to 250% of the mutagenic and cytotoxic activity of its diastereomer. These data strongly suggest that in species capable of the appropriate metabolic transformations of benzo(c)phenanthrene, the 3,4-dihydrodiol and one or both of its diastereomeric bay-region diol-epoxides are proximate and ultimate carcinogens, respectively.

1 To whom requests for reprints should be addressed.

Received 3/14/80. Accepted 5/12/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.